Drug Shortage Report for GD-CELECOXIB
| Report ID | 7589 |
| Drug Identification Number | 02291975 |
| Brand name | GD-CELECOXIB |
| Common or Proper name | GD-CELECOXIB |
| Company Name | GENMED A DIVISION OF PFIZER CANADA ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100's |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-04-28 |
| Actual start date | |
| Estimated end date | 2017-05-31 |
| Actual end date | 2017-06-01 |
| Shortage status | Resolved |
| Updated date | 2017-06-28 |
| Company comments | Resolved June 1, 2017. GD-Celecoxib 200mg will continue to be available GD-Celecoxib 100mg will be available but short dated |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-04-21 | English | Compare |
| v2 | 2017-04-21 | French | Compare |
| v3 | 2017-04-29 | English | Compare |
| v4 | 2017-06-28 | English | Compare |
| v5 | 2017-06-28 | French | Compare |
Showing 1 to 5 of 5